Procaps Group appoints new board directors
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sofgen Pharma SA (PROCF)
Sofgen Pharma SA stock price live, this page displays OTC PROCF stock exchange data. View the PROCF premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sofgen Pharma SA real time stock price chart below.
What Is the Sofgen Pharma SA Stock Price Today?
The Sofgen Pharma SA stock price today is 0.025.
What Is the Stock Symbol for Sofgen Pharma SA?
The stock ticker symbol for Sofgen Pharma SA is PROCF.
Is PROCF the Same as $PROCF?
$PROCF is a common way to refer to the Sofgen Pharma SA ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Sofgen Pharma SA Trade On?
Sofgen Pharma SA is listed and trades on the OTC Markets stock exchange.
Is Sofgen Pharma SA a Good Stock to Buy?
Determining whether Sofgen Pharma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Sofgen Pharma SA share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PROCF quote. (ISIN: LU2376511205)
What Is the Sofgen Pharma SA Stock Price Today?
The Sofgen Pharma SA stock price today is 0.025.
What Is the Stock Symbol for Sofgen Pharma SA?
The stock ticker symbol for Sofgen Pharma SA is PROCF.
Is PROCF the Same as $PROCF?
$PROCF is a common way to refer to the Sofgen Pharma SA ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Sofgen Pharma SA Trade On?
Sofgen Pharma SA is listed and trades on the OTC Markets stock exchange.
Is Sofgen Pharma SA a Good Stock to Buy?
Determining whether Sofgen Pharma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Sofgen Pharma SA share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PROCF quote. (ISIN: LU2376511205)
OTC Markets
Currency in USD
0.025
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.025
0.025
52 wk Range
0.001
1.450
PROCF is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0250.025
52 wk Range
0.0011.450
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PROCF Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Procaps Group appoints new board directors
- Investing.com
- Procaps Group Receives Delisting Notice From Nasdaq
- Investing.com
- Procaps Group Receives Additional Delinquency Letter
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Sofgen Pharma S.A., together with its subsidiaries, develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe. It operates in five segments: NextGel, Procaps Colombia, Central America North (CAN), Central America South and North Andes (CASAND), and Diabetrics. The company develops and manufactures Softgel and related technologies under the Softigel, Sofgen, Softcaps, and Funtrition brands; and Softgel pharmaceutical products, such as Advil, Apronax Liquidgels, multivitamins, Vitamin D, and Dolex ActivGel. It also formulates, manufactures, and markets branded prescription drugs in therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory; and manufactures and markets personal high-complexity drugs for hospital use comprising antibiotics, blood clot, immunosuppressant, oncology, and analgesics products. In addition, the company develops, manufactures, and markets OTC consumer healthcare products consisting of gastrointestinal, skin care, cough and cold, analgesics, urological, and vitamin, minerals, and supplements, as well as antibiotics, anti-infective, and anti-parasitic. Further, it offers blood glucose meters, telemonitoring, Rx oral anti-diabetics products, insulin delivery systems, and other diabetes solutions; and syringes, double chamber syringes, injection vials, injection ampoules, sterilized powder products, sterile droppers, and lyophilized solid vials. The company was formerly known as Procaps Group S.A. Sofgen Pharma S.A. was founded in 1977 and is based in Luxembourg, Luxembourg.
Compare PROCF to Peers and Sector
Metrics to compare | PROCF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPROCFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 12.6x | −0.5x | |
PEG Ratio | 0.00 | 0.12 | 0.00 | |
Price / Book | 0.0x | 1.4x | 2.6x | |
Price / LTM Sales | 0.0x | 2.0x | 3.2x | |
Upside (Analyst Target) | 0.0% | 43.7% | 47.6% | |
Fair Value Upside | Unlock | 34.3% | 6.1% | Unlock |
Earnings
Latest Release
Feb 25, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Sofgen Pharma (PROCF) Stock Price Today?
The Sofgen Pharma stock price today is 0.025 USD.
What Stock Exchange Does Sofgen Pharma Trade On?
Sofgen Pharma is listed and trades on the OTC Markets.
What Is the Stock Symbol for Sofgen Pharma?
The stock symbol for Sofgen Pharma is "PROCF."
What Is the Sofgen Pharma Market Cap?
As of today, Sofgen Pharma market cap is 58.410M USD.
What Is Sofgen Pharma's Earnings Per Share (TTM)?
The Sofgen Pharma EPS (TTM) is -0.681.
When Is the Next Sofgen Pharma Earnings Date?
Sofgen Pharma will release its next earnings report on Jun 12, 2026.
From a Technical Analysis Perspective, Is PROCF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sofgen Pharma Stock Split?
Sofgen Pharma has split 0 times.
How Many Employees Does Sofgen Pharma Have?
Sofgen Pharma has 4498 employees.
What is the current trading status of Sofgen Pharma (PROCF)?
As of Apr 15, 2026, Sofgen Pharma (PROCF) is trading at a price of 0.025 USD, with a previous close of 0.025 USD. The stock has fluctuated within a day range of 0.025 USD to 0.025 USD, while its 52-week range spans from 0.001 USD to 1.450 USD.
What Is the PROCF After Hours Price?
PROCF's last after hours stock price is 0.950 USD, the stock has decreased by -0.060, or -5.930%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.